Investors

BioSeek has raised approximately $29 million in private equity financing.

Venture capital investors in BioSeek include:
Bay City Capital
Fremont Ventures
Vanguard Ventures
SImile Investors LLC

Corporate investor:
Amylin Pharmaceuticals

Individual investors in BioSeek's preferred stock include:
Ronald E. Cape, Ph.D. (founder of Cetus, Darwin Molecular)
Ernest Mario, Ph.D. (CEO, Reliant Pharmaceuticals, former CEO ALZA, Glaxo Holdings PLC)
George Rathmann, Ph.D. (founder, Amgen, ICOS, Nuvelo)